134 related articles for article (PubMed ID: 20846101)
21. Real-world treatment patterns and outcomes in a national study of veterans with Waldenström macroglobulinemia, 2006-2019.
Chien HC; Morreall D; Patil V; Rasmussen KM; Yong CM; Li CY; Passey DG; Burningham Z; Sauer BC; Halwani AS
Am J Hematol; 2021 Jun; 96(6):E184-E187. PubMed ID: 33606890
[No Abstract] [Full Text] [Related]
22. Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia.
Lazarevic VLj; Liljeholm M; Forsberg K; Söderberg S; Wahlin A
Leuk Lymphoma; 2008 Jun; 49(6):1209-11. PubMed ID: 18452089
[No Abstract] [Full Text] [Related]
23. Waldenström's macroglobulinemia: a review of therapy.
Gertz MA
Leuk Lymphoma; 2002 Aug; 43(8):1517-26. PubMed ID: 12400593
[TBL] [Abstract][Full Text] [Related]
24. Nodular amyloidosis of all four eyelids: first presenting symptom of Waldenström macroglobulinaemia.
Jacoby S; Toft PB; Prause JU; Philip P; Heegaard S
Acta Ophthalmol; 2014 Jun; 92(4):392-3. PubMed ID: 23601930
[No Abstract] [Full Text] [Related]
25. Waldenstrom's macroglobulinemia presenting as a perinephric mass.
Therasse CJ; Casalino DD
J Urol; 2011 Nov; 186(5):2067-8. PubMed ID: 21944982
[No Abstract] [Full Text] [Related]
26. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus.
Dimopoulos MA; Kastritis E; Owen RG; Kyle RA; Landgren O; Morra E; Leleu X; García-Sanz R; Munshi N; Anderson KC; Terpos E; Ghobrial IM; Morel P; Maloney D; Rummel M; Leblond V; Advani RH; Gertz MA; Kyriakou C; Thomas SK; Barlogie B; Gregory SA; Kimby E; Merlini G; Treon SP
Blood; 2014 Aug; 124(9):1404-11. PubMed ID: 25027391
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.
Varettoni M; Marchioni E; Bonfichi M; Picchiecchio A; Arcaini L; Arbasino C; Gotti M; Da Vià M; Delmonte M; Sciarra R; Cazzola M
Am J Hematol; 2015 Aug; 90(8):E152-3. PubMed ID: 25975811
[No Abstract] [Full Text] [Related]
28. Selective loss of lymphoid component simulating myeloma in lymphoplasmacytic lymphoma treated with rituximab.
O'Connor SR; Rana SK
Br J Haematol; 2013 May; 161(4):460. PubMed ID: 23530469
[No Abstract] [Full Text] [Related]
29. The Case ∣ Hyperbicarbonatemia in a patient with Waldenstrom's macroglobulinemia. Pseudohyperbicarbonatemia due to paraproteinemia.
Krish P; Jhaveri KD
Kidney Int; 2012 Mar; 81(6):603-5. PubMed ID: 22373713
[No Abstract] [Full Text] [Related]
30. Cladribine for the treatment of indolent non-Hodgkin's lymphomas.
Hoffman MA
Semin Hematol; 1996 Jan; 33(1 Suppl 1):40-4. PubMed ID: 8714616
[No Abstract] [Full Text] [Related]
31. Splenic re-irradiation for waldenstrőm's macroglobulinemia.
Wei Z; Yanxia Y; Ying X; Han W; Yuhua J
Radiat Oncol; 2012 Apr; 7():58. PubMed ID: 22497910
[TBL] [Abstract][Full Text] [Related]
32. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
33. Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.
Hałaburda K; Hellmann A
Acta Haematol Pol; 1994; 25(1):63-7. PubMed ID: 8209618
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of the International Scoring System and response in patients with advanced Waldenstrom macroglobulinemia.
Hivert B; Tamburini J; Vekhoff A; Tournilhac O; Leblond V; Morel P
Haematologica; 2011 May; 96(5):785-8. PubMed ID: 21393333
[No Abstract] [Full Text] [Related]
35. Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen.
Treon SP; Hanzis C; Manning RJ; Ioakimidis L; Patterson CJ; Hunter ZR; Sheehy P; Turnbull B
Br J Haematol; 2011 Aug; 154(3):357-62. PubMed ID: 21615385
[TBL] [Abstract][Full Text] [Related]
36. Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.
Piro LD
Semin Hematol; 1996 Jan; 33(1 Suppl 1):34-9. PubMed ID: 8714615
[No Abstract] [Full Text] [Related]
37. Marked increase in serum IgM during treatment of Waldenstrom's macroglobulinemia with cladribine.
Krishna VM; Carey RW; Bloch KJ
N Engl J Med; 2003 May; 348(20):2045-6. PubMed ID: 12748329
[No Abstract] [Full Text] [Related]
38. Tumoral Bing-Neel Syndrome presenting as a cerebellar mass.
Rigual D; Qiu J; Fenstermaker RA; Fabiano AJ
Clin Neurol Neurosurg; 2013 Jun; 115(6):823-6. PubMed ID: 22902079
[No Abstract] [Full Text] [Related]
39. Waldenström macroglobulinemia: my way.
Gertz M
Leuk Lymphoma; 2013 Mar; 54(3):464-71. PubMed ID: 22860921
[TBL] [Abstract][Full Text] [Related]
40. Extramedullary, extranodal lymphoplasmacytic lymphoma with macroglobulinemia: long-term complete remission with fludarabine.
Christopoulos C; Fortis A; Tassidou A; Anevlavis E
Ann Hematol; 2008 Feb; 87(2):159-61. PubMed ID: 17724597
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
